Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]
News [3579]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
Atezolizumab in metastatic TNBC: Long-term clinical outcomes and biomarker...
Prof Peter Schmid - Barts Cancer Institute, London, UK
Atezolizumab in metastatic TNBC: Long-term clinical outcomes and biomarker analyses ( Prof Peter Schmid - Barts Cancer Institute, London, UK )
11 Apr 2017
Five-year follow-up of nivolumab in NSCLC
Prof Julie Brahmer - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA
Five-year follow-up of nivolumab in NSCLC ( Prof Julie Brahmer - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )
11 Apr 2017
Mechanisms of resistance in triple negative breast cancer
Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia
Mechanisms of resistance in triple negative breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )
24 Mar 2017
IMW 2017 highlights
Dr Laurent Garderet - Hôpital Saint Antoine, Paris, France
IMW 2017 highlights ( Dr Laurent Garderet - Hôpital Saint Antoine, Paris, France )
7 Mar 2017
Treatment of multiple myeloma patients in the relapsed setting: Expert...
Prof Maria-Victoria Mateos, Prof Paul Richardson
Treatment of multiple myeloma patients in the relapsed setting: Expert discussion from IMW 2017 ( Prof Maria-Victoria Mateos, Prof Paul Richardson )
5 Mar 2017
Multiple myeloma highlights from IMW 2017
Prof Phillipe Moreau, Prof Philip McCarthy, Prof Jens Hillengass, Prof Meletios...
Multiple myeloma highlights from IMW 2017 ( Prof Phillipe Moreau, Prof Philip McCarthy, Prof Jens Hillengass, Prof Meletios Dimopoulos )
4 Mar 2017
Role of immunotherapy and precision medicines in multiple myeloma and key new...
Prof Sagar Lonial - Emory University, Atlanta, USA
Role of immunotherapy and precision medicines in multiple myeloma and key new guidelines ( Prof Sagar Lonial - Emory University, Atlanta, USA )
3 Mar 2017
Denosumab vs zoledronic acid for bone disease in newly diagnosed multiple...
Prof Evangelos Terpos - University of Athens School of Medicine, Athens, Greece
Denosumab vs zoledronic acid for bone disease in newly diagnosed multiple myeloma ( Prof Evangelos Terpos - University of Athens School of Medicine, Athens, Greece )
3 Mar 2017
Monoclonal antibodies in multiple myeloma
Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain
Monoclonal antibodies in multiple myeloma ( Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain )
2 Mar 2017
Treatment options for newly diagnosed multiple myeloma and management of bone...
Prof Sonneveld, Prof Cavo, Prof Terpos and Professor Voorhees
Treatment options for newly diagnosed multiple myeloma and management of bone disease: Roundtable at IMW 2017 ( Prof Sonneveld, Prof Cavo, Prof Terpos and Professor Voorhees )
2 Mar 2017
Promising myeloma agents in phase II trials
Dr Ruben Niesvizky - New York Presbyterian Hospital-Weill Cornell Medical...
Promising myeloma agents in phase II trials ( Dr Ruben Niesvizky - New York Presbyterian Hospital-Weill Cornell Medical Center, New York, USA )
2 Mar 2017
Examining strategies to tailor multiple myeloma immunotherapy
Dr Jeffrey Zonder - Karmanos Cancer Institute, Detroit, USA
Examining strategies to tailor multiple myeloma immunotherapy ( Dr Jeffrey Zonder - Karmanos Cancer Institute, Detroit, USA )
2 Mar 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation